These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19533783)

  • 1. Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective.
    Christiaans I; van Langen IM; Birnie E; Bonsel GJ; Wilde AA; Smets EM
    Am J Med Genet A; 2009 Jul; 149A(7):1444-51. PubMed ID: 19533783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy.
    Christiaans I; Birnie E; Bonsel GJ; Mannens MM; Michels M; Majoor-Krakauer D; Dooijes D; van Tintelen JP; van den Berg MP; Volders PG; Arens YH; van den Wijngaard A; Atsma DE; Helderman-van den Enden AT; Houweling AC; de Boer K; van der Smagt JJ; Hauer RN; Marcelis CL; Timmermans J; van Langen IM; Wilde AA
    Eur Heart J; 2011 May; 32(9):1161-70. PubMed ID: 21459882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study.
    Christiaans I; van Langen IM; Birnie E; Bonsel GJ; Wilde AA; Smets EM
    Am J Med Genet A; 2009 Feb; 149A(4):602-12. PubMed ID: 19253387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.
    Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D
    Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling and testing for hypertrophic cardiomyopathy: the pediatric perspective.
    Demo EM; Skrzynia C; Baxter S
    J Cardiovasc Transl Res; 2009 Dec; 2(4):500-7. PubMed ID: 20560008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counseling and testing for hypertrophic cardiomyopathy: an adult perspective.
    Skrzynia C; Demo EM; Baxter SM
    J Cardiovasc Transl Res; 2009 Dec; 2(4):493-9. PubMed ID: 20560007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Uptake of Genetics Services for Hypertrophic Cardiomyopathy.
    Khouzam A; Kwan A; Baxter S; Bernstein JA
    J Genet Couns; 2015 Oct; 24(5):797-809. PubMed ID: 25566741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A good idea: a physician's perspective on genetic counseling for hypertrophic cardiomyopathy.
    Patterson C
    J Cardiovasc Transl Res; 2009 Dec; 2(4):508-9. PubMed ID: 20560009
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance of Hypertrophic Cardiomyopathy in Children Who Are Mutation Positive.
    Vermeer AMC; Clur SB; Blom NA; Wilde AAM; Christiaans I
    J Pediatr; 2017 Sep; 188():91-95. PubMed ID: 28396031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey.
    van Langen IM; Birnie E; Schuurman E; Tan HL; Hofman N; Bonsel GJ; Wilde AA
    Clin Genet; 2005 Oct; 68(4):360-8. PubMed ID: 16143023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers.
    Christiaans I; Kok TM; van Langen IM; Birnie E; Bonsel GJ; Wilde AA; Smets EM
    Eur J Hum Genet; 2010 Feb; 18(2):251-3. PubMed ID: 19672285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death.
    Konno T; Shimizu M; Ino H; Fujino N; Uchiyama K; Mabuchi T; Sakata K; Kaneda T; Fujita T; Masuta E; Mabuchi H
    Clin Sci (Lond); 2006 Jan; 110(1):125-31. PubMed ID: 16181148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up.
    Hamang A; Eide GE; Rokne B; Nordin K; Bjorvatn C; Øyen N
    J Genet Couns; 2012 Feb; 21(1):72-84. PubMed ID: 21773878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.
    van Velzen HG; Schinkel AFL; Menting ME; van den Bosch AE; Michels M
    J Ultrasound; 2018 Sep; 21(3):217-224. PubMed ID: 29876904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies.
    Wynn J; Holland DT; Duong J; Ahimaz P; Chung WK
    J Genet Couns; 2018 Aug; 27(4):927-934. PubMed ID: 29243008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
    Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
    Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.